S
PMVP icon

SignatureFD’s PMV Pharmaceuticals PMVP Stock Holding History

SignatureFD’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-440
Closed -$2.1K – 3338
2023
Q1 		$2.1K Buy
440
+138
+46% +$971 ﹤0.01% 2793
2022
Q4 		$2.63K Buy
302
+224
+287% +$2.39K ﹤0.01% 2720
2022
Q3 		$1K Sell
78
-84
-52% -$1.21K ﹤0.01% 3010
2022
Q2 		$2K Buy
162
+19
+13% +$277 ﹤0.01% 2789
2022
Q1 		$3K Buy
+143
New +$2.52K ﹤0.01% 2712
2021
Q4 		– Sell
-29
Closed -$1K – 3229
2021
Q3 		$1K Buy
+29
New +$926 ﹤0.01% 2890

Other funds holding PMVP

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SignatureFD's PMVP Position: Q2 2023 in Review

SignatureFD sold out of PMV Pharmaceuticals (PMVP) in Q2 2023, closing a stake of 440 shares — an estimated $2.1K sold.

SignatureFD first reported a position in PMVP in Q3 2021 and held it in 6 quarters. The position peaked at $3K in Q1 2022. 106 funds tracked by Wall St. Rank hold PMVP as of Q2 2023.

  • SignatureFD reported no remaining PMV Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • SignatureFD sold 440 PMV Pharmaceuticals shares in Q2 2023, an estimated $2.1K.
  • SignatureFD first reported a position in PMV Pharmaceuticals in Q3 2021 and held it in 6 quarters.
  • SignatureFD's PMV Pharmaceuticals position peaked at $3K in Q1 2022.
  • 106 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q2 2023.

Based on SignatureFD's 13F filing for Q2 2023, filed 1 Aug 2023.